NPR logo

Controversy over Outsourcing Drug Clinical Trials to India

  • Download
  • <iframe src="https://www.npr.org/player/embed/3850929/3850930" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Controversy over Outsourcing Drug Clinical Trials to India

Global Health

Controversy over Outsourcing Drug Clinical Trials to India

Controversy over Outsourcing Drug Clinical Trials to India

  • Download
  • <iframe src="https://www.npr.org/player/embed/3850929/3850930" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Many U.S. technology jobs have been outsourced to India, and now there are reports medical research is being transferred there, too. Clinical trials that cost millions in the United States cost only thousands to perform in India. It's raising questions about the ethics of using subjects who have little exposure to Western medicine, and whether they're fully aware of the risks and benefits of participating in drug trials. One issue: There may be no benefit to those suffering illness in India if the drugs being tested are too expensive for poor Indians to afford. Reporter Fred de Sam Lazaro of Twin Cities Public Television reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.